Search Results
Apr 16, 2026, 09:54 ET Global Neonatal Ventilators Market to Reach USD 590.40 Million by 2031 | More than 15 Million Preterm Births Driving Demand in NICUs - Exclusive Market Research by Arizton
analysis 1500+ reports published till date Post-Purchase Benefit 1hr of free analyst discussion 10% off on customization About
More news about: Arizton Advisory & Intelligence
Apr 16, 2026, 09:49 ET Resolve AI announces Series A Extension at a $1.5B valuation and launches Resolve AI Labs to advance AI systems for complex production environments
Resolve AI Labs will be led by Dhruv Mahajan, who joins Resolve AI as Chief AI Scientist. Before joining Resolve AI, Dhruv was part of Meta, where he led post-training efforts for large-scale Llama foundation models. At Resolve AI, he will apply that experience to building the domain-specific models, evaluation
More news about: Resolve AI
Apr 16, 2026, 09:30 ET Virginia Green Expands in Coastal North Carolina Through Partnership with Turf Medic
warm-season lawnsAdvanced agronomic practices supported by modern, high‑efficiency equipmentImproved customer communication with pre- and post-service notificationsConvenient online account management toolsAccess to Virginia Green's 100% Satisfaction Guarantee"Our
More news about: Virginia Green Lawn Care
Apr 16, 2026, 09:24 ET AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
review of the Company's NDA for Anaphylm, the FDA notified us that it had identified deficiencies in the NDA that preclude discussion of labeling and post-marketing commitments at this time," stating that "the notification did not specify the deficiencies[.]"On this news, Aquestive's stock price
More news about: Faruqi & Faruqi, LLP
Apr 16, 2026, 09:17 ET ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
Biologics License Application (BLA) as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy including an anti-CD20 containing regimen." Atara said
More news about: Faruqi & Faruqi, LLP
Apr 16, 2026, 09:05 ET PointClickCare and AIDA Healthcare Partner to Revolutionize Referral Management, Streamline Patient Care Transitions, and Reduce Costs Nationwide
AdventHealth, and Froedtert Hospital, titled "Navigating Complexity in Acute-to-Post-Acute Transitions." The session will explore the systemic barriers case managers face during care transitions, including fragmented workflows, limited post-acute visibility, and inconsistent information. It will also highlight
More news about: PointClickCare
Apr 16, 2026, 09:00 ET Sabre announces upcoming webcast of its first quarter 2026 earnings conference call
www.sabre.com. Website Information We routinely post important information for investors on the Investor Relations section of our website,
More news about: Sabre Corporation
Apr 16, 2026, 09:00 ET tendercare Expands Trusted Network with Vivo Fitness and Assisting Hands® Home Care, Cementing Its Position as the Front Door to Eldercare
caregivers deliver 24/7 support across the full spectrum of in-home needs: companionship, personal care, Alzheimer's and dementia support, Parkinson's care, post-surgical recovery, and hospice. Assisting Hands is also a VA-approved provider and has been named to Entrepreneur's Franchise 500.Being named
More news about: tendercare
Apr 16, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt
Soleno reported $32.7 million in DCCR revenue and held a conference call during which management stated there were "no new safety signals" in the post-marketing setting and that discontinuation rates were "substantially lower than what we saw even in clinical trials." The securities action claims these
More news about: SueWallSt.com
Apr 16, 2026, 09:00 ET NAVAN PROMISED 'RAPID GROWTH' BUT HID $95M EXPENSE SURGE FROM IPO INVESTORS: SUEWALLST, LLP
rates. None of this was shared with IPO purchasers.Promise vs. Actual: By the NumbersIPO price: $25.00 per share | Post-disclosure low: $9.20 per shareSales and marketing (Q ending July 31, 2025): $68.5 million | Sales and marketing (Q ending October 31, 2025):
More news about: SueWallSt.com
Apr 16, 2026, 09:00 ET ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Disregarded FDA Requirements: SueWallSt
based on repeated claims of consistent clinical trial results now face a 70.7% loss following the FDA's findings." — Joseph E. Levi, Esq.Post-Deadline ProceduresAfter May 29, 2026, the court will review competing motions and appoint a lead plaintiff. Absent class members need take
More news about: SueWallSt.com
Apr 16, 2026, 09:00 ET MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Defendants Allegedly Violated Securities Disclosure Laws: SueWallSt
participate as absent class members and share in any recoveryMultiple investors may apply jointly as a lead plaintiff groupPost-Deadline ProceduresAfter the June 8, 2026 deadline passes, the United States District Court for the Southern District of Ohio will review
More news about: SueWallSt.com
Apr 16, 2026, 09:00 ET City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
types."The City of Hope clinical trials are investigating Haystack MRD across patient management settings, including neoadjuvant, adjuvant and post-treatment surveillance. The research is evaluating if the test can detect minimal residual disease, monitor treatment response, and identify recurrence
More news about: Quest Diagnostics
Apr 16, 2026, 09:00 ET GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing to Disclose Trial Risks: SueWallSt
80% of their investment in a single day following the PROSERA disclosure, selecting an engaged lead plaintiff is particularly important."Post-Deadline ProceduresAfter June 1, 2026, the Court will review all lead plaintiff applications and appoint the investor or group it determines
More news about: SueWallSt.com
Apr 16, 2026, 09:00 ET Worki Raises $2.75 Million to Build the AI Workforce Unifying Infrastructure Layer for Healthcare Workforce Operations
standardization process. Once established, Worki deploys AI agents that amplify existing workforce roles with people in the middle, accelerating ERP readiness, post-merger system unification, and reducing administrative burden across each effort.The company's task-role architecture creates an actionable
More news about: Worki
Apr 16, 2026, 09:00 ET NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
presentations at the American Academy of Neurology (AAN) Annual Meeting to be held April 18-22 in person in Chicago and online. The first presentation is a post-hoc analysis of pooled data from long-term safety studies evaluating the immediate-use seizure medication (ISM) diazepam nasal spray for the prehospital
More news about: Neurelis, Inc.
Apr 16, 2026, 08:41 ET Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law,
More news about: Berger Montague
Apr 16, 2026, 08:41 ET WorldViz VR Unveils 2026 Budgeting Guidelines for Scientific VR Labs
https://www.worldviz.com/post/worldviz-vr-budgeting-guidelines-for-scientific-vr-labs.About WorldViz VRBased in Santa Barbara, CA, WorldViz VR is a leading provider of immersive
More news about: WorldViz VR
Apr 16, 2026, 08:30 ET Visual Pharma by Powtoon Named LTEN Excellence Awards Finalist for MOA Studio, Advancing Compliant AI-Powered Scientific Communication
thousands of dollars per asset. These constraints limit agility across the product lifecycle, from early clinical communication to launch readiness and post-launch updates.MOA Studio introduces a new modelBuilt on a structured AI framework aligned to clinical source documentation, the
More news about: Powtoon
Apr 16, 2026, 08:00 ET Avid and Google Cloud Announce Partnership to Bring Agentic AI to Media Production
Strategic collaboration integrates Gemini models and Vertex AI into Avid Media Composer and Avid Content Core to automate time-intensive film and TV post-production tasksBURLINGTON, Mass. and SUNNYVALE, Calif., April 16, 2026
More news about: Google Cloud
Apr 16, 2026, 08:00 ET DTCC and CME Group Receive Regulatory Approvals to Launch Expanded U.S. Treasury Cross-Margining Arrangement for End-User Clients
SYDNEY, April 16, 2026 /PRNewswire/ -- The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, and CME Group, the world's leading derivatives marketplace, today announced
More news about: CME Group
Apr 16, 2026, 08:00 ET EventPipe Foundation Launches to Expand Access to Youth Sports
inventory management and reconciliation. Alongside its core block management platform, EventPipe offers live hotel inventory capabilities that capture post-block reservations and power standalone booking sites.About the EventPipe Foundation
More news about: EventPipe
Apr 16, 2026, 08:00 ET BRAINBox Solutions Announces Expansion of Patent Portfolio Covering Diagnostic and Prognostic Technology for Concussion and Neurodegenerative Disease Tests
using standard laboratory systems, as well as neurocognitive testing, to provide a single–system score that measures the severity of the injury and post-concussive symptoms. The company is led by key physician and scientific thought leaders in the field and an experienced, clinically focused management
More news about: BRAINBox Solutions, Inc.
Apr 16, 2026, 08:00 ET Uranium Royalty, Orion and Ontario Teachers' Pension Plan to Create a Leading Royalty Platform Through Combination of Uranium Royalty and Sweetwater Royalties
Company's shareholders; the satisfaction of the conditions precedent to the Transaction; the strengths, characteristics and potential of New URC post-Transaction; growth potential of New URC, timing, receipt and anticipated effects of court and other approvals; expectations regarding uranium and soda ash
More news about: Uranium Royalty Corp.
Apr 16, 2026, 07:55 ET Mega Matrix Announces Fiscal 2025 Annual Results on Form 20-F: Dual-Engine Strategy Delivers Operational Efficiency, Margin Improvement and Strategic Web3 Growth
www.megamatrix.io) to host social media disclosures and/or links to/from such disclosures. The information we post through these social media channels may be deemed material. Accordingly, investors should monitor these social media channels in addition to following
More news about: Mega Matrix Inc.